Advancements and Obstacles of PARP Inhibitors in Gastric Cancer

Abstract excerpt

Gastric cancer (GC) is a common and aggressive cancer of the digestive system, exhibiting high aggressiveness and significant heterogeneity. Despite advancements in improving survival rates over the past few decades, GC continues to carry a worrisome prognosis and notable mortality. As a result, there is an urgent need for novel therapeutic approaches to address GC. Recent targeted sequencing studies have...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Colorectal and Anal Carcinomas
• Share to DNA Repair Mechanisms
• Share to PARP inhibition in cancer therapy